tiprankstipranks
Trending News
More News >
Clinuvel Pharmaceuticals Limited (CLVLF)
OTHER OTC:CLVLF
US Market

Clinuvel Pharmaceuticals (CLVLF) Stock Forecast & Price Target

Compare
37 Followers
See the Price Targets and Ratings of:

CLVLF Financial Forecast

CLVLF Earnings Forecast

Next quarter’s earnings estimate for CLVLF is $0.24 with a range of $0.20 to $0.28. The previous quarter’s EPS was $0.18. CLVLF beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.03% of the time in the same period. In the last calendar year CLVLF has Outperformed its overall industry.
Next quarter’s earnings estimate for CLVLF is $0.24 with a range of $0.20 to $0.28. The previous quarter’s EPS was $0.18. CLVLF beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.03% of the time in the same period. In the last calendar year CLVLF has Outperformed its overall industry.

CLVLF Sales Forecast

Next quarter’s sales forecast for CLVLF is $39.62M with a range of $38.84M to $40.18M. The previous quarter’s sales results were $22.77M. CLVLF beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.53% of the time in the same period. In the last calendar year CLVLF has Outperformed its overall industry.
Next quarter’s sales forecast for CLVLF is $39.62M with a range of $38.84M to $40.18M. The previous quarter’s sales results were $22.77M. CLVLF beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.53% of the time in the same period. In the last calendar year CLVLF has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on CLVLF
David StantonJefferies
Jefferies
$25.47$25.63
Buy
255.05%
Upside
Reiterated
03/03/25
Jefferies Sticks to Their Buy Rating for Clinuvel Pharmaceuticals Limited (CLVLF)
Wilsons
$19.49
Buy
170.00%
Upside
Reiterated
02/28/25
Bell Potter Analyst forecast on CLVLF
Thomas WakimBell Potter
Bell Potter
$14.13
Buy
95.75%
Upside
Reiterated
02/27/25
Analysts Offer Insights on Healthcare Companies: Mesoblast Limited (Other OTC: MEOBF) and Clinuvel Pharmaceuticals Limited (Other OTC: CLVLF)
MA Financial Group Analyst forecast on CLVLF
Sarah MannMA Financial Group
MA Financial Group
$14.95
Buy
107.00%
Upside
Reiterated
10/30/24
MA Financial Group Sticks to Its Buy Rating for Clinuvel Pharmaceuticals Limited (CLVLF)
Morgans
$10.4$11.05
Buy
53.00%
Upside
Reiterated
08/30/24
Clinuvel Pharmaceuticals Limited (CLVLF) Gets a Buy from Morgans
Ord Minnett Analyst forecast on CLVLF
Unknown AnalystOrd Minnett
Not Ranked
Ord Minnett
$11.7
Buy
62.00%
Upside
Upgraded
06/19/24
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on CLVLF
David StantonJefferies
Jefferies
$25.47$25.63
Buy
255.05%
Upside
Reiterated
03/03/25
Jefferies Sticks to Their Buy Rating for Clinuvel Pharmaceuticals Limited (CLVLF)
Wilsons
$19.49
Buy
170.00%
Upside
Reiterated
02/28/25
Bell Potter Analyst forecast on CLVLF
Thomas WakimBell Potter
Bell Potter
$14.13
Buy
95.75%
Upside
Reiterated
02/27/25
Analysts Offer Insights on Healthcare Companies: Mesoblast Limited (Other OTC: MEOBF) and Clinuvel Pharmaceuticals Limited (Other OTC: CLVLF)
MA Financial Group Analyst forecast on CLVLF
Sarah MannMA Financial Group
MA Financial Group
$14.95
Buy
107.00%
Upside
Reiterated
10/30/24
MA Financial Group Sticks to Its Buy Rating for Clinuvel Pharmaceuticals Limited (CLVLF)
Morgans
$10.4$11.05
Buy
53.00%
Upside
Reiterated
08/30/24
Clinuvel Pharmaceuticals Limited (CLVLF) Gets a Buy from Morgans
Ord Minnett Analyst forecast on CLVLF
Unknown AnalystOrd Minnett
Not Ranked
Ord Minnett
$11.7
Buy
62.00%
Upside
Upgraded
06/19/24
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Clinuvel Pharmaceuticals

1 Month
xxx
Success Rate
1/7 ratings generated profit
14%
Average Return
-4.24%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 14.29% of your transactions generating a profit, with an average return of -4.24% per trade.
3 Months
xxx
Success Rate
1/7 ratings generated profit
14%
Average Return
-9.23%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 14.29% of your transactions generating a profit, with an average return of -9.23% per trade.
1 Year
Sarah MannMA Financial Group
Success Rate
0/3 ratings generated profit
0%
Average Return
-18.60%
reiterated a buy rating 8 months ago
Copying Sarah Mann's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -18.60% per trade.
2 Years
xxx
Success Rate
0/7 ratings generated profit
0%
Average Return
-21.09%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -21.09% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CLVLF Analyst Recommendation Trends

Rating
Sep 24
Oct 24
Jan 25
Feb 25
Mar 25
Strong Buy
7
7
3
4
4
Buy
0
0
0
0
0
Hold
1
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
7
3
4
4
In the current month, CLVLF has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CLVLF average Analyst price target in the past 3 months is 25.48.
Each month's total comprises the sum of three months' worth of ratings.

CLVLF Stock Forecast FAQ

What is CLVLF’s average 12-month price target, according to analysts?
Based on analyst ratings, Clinuvel Pharmaceuticals Limited’s 12-month average price target is 25.48.
    What is CLVLF’s upside potential, based on the analysts’ average price target?
    Clinuvel Pharmaceuticals Limited has 252.91% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CLVLF a Buy, Sell or Hold?
          Clinuvel Pharmaceuticals Limited has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Clinuvel Pharmaceuticals Limited’s price target?
            The average price target for Clinuvel Pharmaceuticals Limited is 25.48. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $25.48 ,the lowest forecast is $25.48. The average price target represents 252.91% Increase from the current price of $7.22.
              What do analysts say about Clinuvel Pharmaceuticals Limited?
              Clinuvel Pharmaceuticals Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of CLVLF?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis